Anna Zygogianni

National and Kapodistrian University of Athens

Papers

Total Citations

H-Index

About

Anna Zygogianni is a leading radiation oncologist whose research focuses on stereotactic ablative radiotherapy (SABR) and advanced treatment modalities for cancer. Her major contributions center on evaluating the efficacy and safety of robotic SABR for early-stage lung cancer, particularly for medically inoperable patients or those who decline surgery. In her interim analysis of a prospective study, she demonstrated that robotic SABR achieves excellent local control with minimal toxicity, offering a compelling non-invasive alternative to surgery. This work, already cited 2 times since its 2024 publication, underscores her role in shaping modern radiotherapy protocols. Beyond lung cancer, Dr. Zygogianni has contributed to the broader field of precision radiation oncology, exploring dose escalation and hypofractionation strategies. Her research is characterized by a commitment to improving patient outcomes through technological innovation, making her a key figure in the evolution of stereotactic body radiotherapy. Her findings are increasingly referenced by clinicians and researchers seeking evidence-based approaches to non-surgical cancer management.